GET DAILY SIGNALSEdgewell Personal Care (EPC): Can the Stock Reach $35 for +22% Upside?
Key Takeaways
- The $35 stock price target examined here comes from public discussion, not a formal analyst consensus; it is most closely tied to RBC Capital's $35 target and Canaccord Genuity's $34 target.
- At a latest price near $28.74, reaching $35 implies roughly 22% upside, a substantial but not unrealistic move.
- The six verified analyst targets span $29 to $35 and average about $31.50, only about 9.6% above the current price, which is too narrow a gap to serve as a meaningful "reach" question.
- The strongest support comes from the board's rejection of a $30-per-share takeover bid as undervaluing the company, plus a quarterly earnings beat and a sharper focus on higher-value brands.
- The biggest risks are soft organic sales, pressure on margins in consumer staples, and uncertainty about whether any higher takeover offer will emerge.
- Investors can explore additional context on the Major News, Today's Price Move, Forecast, and Earnings pages for EPC.
- Readers can also explore Trending AI Robots to see how automated systems are monitoring names like EPC in real time.
How the $35 Price Target Came Into Focus
With the average analyst target sitting too close to the current share price to offer much insight, the $35 level comes from specific public commentary rather than a broad consensus. RBC Capital kept its Buy rating and $35 target in November 2026, while Canaccord Genuity's Susan Anderson has held a Buy with a $34 objective. These views followed Edgewell's decision to turn down an unsolicited $30-per-share offer from Yellow Wood Partners, which the board viewed as understating the company's longer-term value.
Six analyst targets are on record: RBC Capital at $35, Barclays at $29, UBS at $30, Wells Fargo at $30, Canaccord Genuity at $34, and Morgan Stanley at $31. The average works out to roughly $31.50, with the range running from $29 to $35 and an overall cautious "hold" tone rather than strong buy signals across the board.
Where EPC Stands Today and the Path to $35
Shares of Edgewell Personal Care have been trading near $28.74, for a market capitalization around $1.3 billion. Hitting $35 would mean about 22% upside, a meaningful gain for a mature consumer staples name. The stock has already moved higher over the past six months and sits near its 52-week high of roughly $30.36, above the 50-day moving average near $27.84 and the 200-day average near $24.28.
Getting there would probably depend on either a higher takeover bid or clear signs that the company's brand refocus can restore organic growth. Edgewell has shifted emphasis by treating its feminine-care business as discontinued operations and highlighting faster-growing areas such as Billie in women's shaving and premium grooming lines.
Elements That Could Help Push Toward the Target
- Takeover interest as a value signal. Rejecting the $30 bid suggests management sees greater intrinsic worth, and analysts responded by lifting their targets.
- Earnings momentum. The latest quarter showed EPS of $0.78 against a $0.77 estimate and revenue of $484.1 million versus expected $479.9 million.
- Guidance consistency. Fiscal 2027 EPS guidance of $1.85 to $2.15 and revenue around $2.0 billion aligned with expectations.
- Brand mix. Schick, Billie, Banana Boat, Hawaiian Tropic, Bulldog, and Jack Black give exposure to everyday products along with a dividend yield near 2%.
Obstacles That Could Keep the Target Out of Reach
- Soft organic sales trends. Revenue has declined year over year in recent quarters amid softer consumer demand and competition.
- Margin challenges. Trailing net margin has been negative, partly due to restructuring and impairment charges.
- Analyst divergence. The $29 low end of the range sits close to the current price, indicating limited near-term upside in some views.
- Takeover uncertainty. Without a higher bid, the stock could shed the premium tied to deal speculation.
- Consumer staples pressures. Inflation, promotions, and trading down can weigh on volumes and pricing.
Technical Levels Worth Watching
The 52-week range of about $15.73 to $30.36 sets the current context. The $30 zone stands out because it matches both the rejected bid price and a psychological round-number level just under the 52-week high. A sustained move past $30.36 could open the door to new highs, with $35 as the next frequently mentioned objective. On the downside, the 50-day average near $27.84 and 200-day average near $24.28 remain the main support areas.
Time Frame and Key Items to Follow
Analyst targets generally look out about 12 months, though assumptions differ. Since the $35 level partly reflects takeover speculation, timing remains uncertain. I am watching the next earnings report and guidance, any target revisions, shifts in consumer staples demand, and potential acquisition developments. A formal offer above $30 would be the clearest catalyst, while a guidance cut or weaker demand would challenge the case.
Using Tickeron Tools in My Research
I also checked this using Tickeron’s AI Daily Buy/Sell Signals to see how the stock compares to others in the industry.
Exploring AI Daily Buy/Sell Signals for Broader Context
In my own work, Tickeron's AI Daily Buy/Sell Signals have been a useful way to track momentum across a wide range of names without relying solely on manual checks. The system applies artificial intelligence to scan thousands of stocks and ETFs, generating Buy, Sell, or Hold signals as conditions and technical patterns shift. For anyone following EPC, this offers a structured approach to spotting changes in trend. I find it helpful for keeping an eye on existing holdings and identifying fresh ideas more efficiently.
Final Assessment
Whether Edgewell Personal Care can reach $35 ultimately hinges on whether takeover interest or an operational turnaround can support a valuation about 22% above current levels. The case draws strength from bullish targets at RBC Capital and Canaccord Genuity along with the board's rejection of the $30 bid, yet the wider analyst range of $29 to $35 reveals genuine differences of opinion, with the $31.50 average pointing to only modest upside. Recent earnings beats and brand focus provide backing, while soft sales, margin pressure, and deal uncertainty stand as the main hurdles. No result is assured, and investors should balance the takeover premium against underlying fundamentals.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
EPC in -5.63% downward trend, declining for three consecutive days on November 06, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where EPC declined for three days, in 182 of 295 cases, the price declined further within the following month. The odds of a continued downward trend are 62%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 36 of 59 cases where EPC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 61%.
EPC broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on EPC as a result. In 50 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.
The Moving Average Convergence Divergence (MACD) for EPC just turned positive on October 29, 2026. Looking at past instances where EPC's MACD turned positive, the stock continued to rise in 26 of 42 cases over the following month. The odds of a continued upward trend are 62%.
EPC moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for EPC crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 59%.
Following a +5.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where EPC advanced for three days, in 211 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
The Aroon Indicator entered an Uptrend today. In 147 of 228 cases where EPC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 19 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.884) is normal, around the industry mean (21.731). P/E Ratio (-14.065) is within average values for comparable stocks, (16.288). EPC's Projected Growth (PEG Ratio) (3.530) is slightly higher than the industry average of (1.518). Dividend Yield (0.021) settles around the average of (0.032) among similar stocks. P/S Ratio (0.554) is also within normal values, averaging (1.902).
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. EPC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EPC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a maker of skin care and other personal care products
Industry HouseholdPersonalCare
Advertisement